Sartorius Stedim Biotech S.A. (SDMHF)

Market Cap	19.77B
Revenue (ttm)	2.88B
Net Income (ttm)	181.28M
Shares Out	n/a
EPS (ttm)	1.87
PE Ratio	109.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Average Volume	2,889
Open	208.00
Previous Close	200.95
Day's Range	200.95 - 208.00
52-Week Range	158.00 - 299.86
Beta	0.78
RSI	26.93
Earnings Date	Apr 16, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 9,901
• Stock Exchange: OTCMKTS
• Ticker Symbol: SDMHF

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.

Financial numbers in EUR